Elanco Animal Health (ELAN) Issues Innovation Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Elanco Provides Innovation Update
June 27, 2024 6:27 AM EDTMajor technical sections complete for Zenrelia, with FDA final approval on track for late in third quarter of 2024; updates on differentiation and safety Final FDA approval for Credelio Quattro now expected in the fourth quarter of 2024First Zenrelia approval received in Brazil 2024 Innovation sales guidance increased
GREENFIELD, Ind., June 27, 2024 /PRNewswire/ --Â Elanco Animal Health Incorporated (NYSE: ELAN) today announced updates to the expected... More



